Galiellalactone (GL) inhibits the binding of activated STAT3 to DNA, reduces ALDHhigh PCa population, downregulates ALDH1A1, and sensitizes chemotherapy (65, 104). Here, STAT3 is linked to posterior cortical atrophy.